Contrast Injectors Market

Contrast Injectors Market by Product (Injector Systems (CT Injector, MRI Injector), Consumables (Injector Head, Tubing), Accessories), & Application (Radiology, Interventional Cardiology, Interventional Radiology) - Global Forecast to 2021

Report Code: MD 5244 May, 2017, by marketsandmarkets.com

[125 Pages Report] The contrast injectors market is projected to reach USD 636.1 Million by 2021 from USD 445.5 Million in 2016, growing at a CAGR of 7.4% during the forecast period. The contrast injector market growth can primarily be attributed to factors such as the large number of approvals for contrast agents in different geographies and increasing number of public and private diagnostic centers. On the other hand, the side effects and allergic reactions associated with contrast agents are expected to limit the market growth to a certain extent. In the coming years, the contrast media injector market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in the region can be attributed to the rising approvals for various contrast agents in Asia-Pacific countries, developing markets, and the growing presence of international players in this region. In addition, the availability of government support for research, high healthcare expenditures in APAC countries, rising aging population, and increasing cancer incidences are expected to support the growth of the Asia-Pacific contrast injector market.

On the basis of product, the contrast injector market is categorized into injector systems, consumables, and accessories. In 2016, the consumables segment is estimated to account for the largest share of the contrast injector market. This growth is mainly attributed to the recurring use of consumables in diagnostic procedures to maintain hygienic conditions. The injector systems segment is further divided into CT injector systems, MRI injector systems, and angiography injector systems. In 2016, the CT injector systems segment is expected to command the largest share of the market. The MRI injector systems segment is expected to grow at the highest CAGR during the forecast period. The consumables segment is further divided into injector heads, syringes, tubing, and other consumables (scan bags, valves, vials, and spikes). In 2016, the injector heads segment is estimated to account for the largest share of the consumables market. The injector heads segment is further categorized into single head injectors, dual head injectors, and syringeless injectors. The single head injectors segment is expected to command the largest share of the market, in 2016. The syringeless injectors segment is projected to grow at the highest CAGR during the forecast period.

On the basis of application, the contrast injector market is segmented into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to account for the largest share of the global market in 2016. Factors such as the increasing use of contrast agents in various diagnostic procedures/centers are expected to drive the contrast injectors market for radiology applications. The interventional cardiology segment is expected to grow at the highest CAGR during the forecast period.

On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America is estimated to account for the largest share of the contrast injector market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is expected to grow at the highest CAGR during the forecast period, and also serve as a revenue pocket for companies offering contrast injectors.

The prominent players in the global contrast injector market include Bracco Imaging S.p.A. (Italy), Bayer HealthCare (Germany), and Guerbet Group (France) in 2015. These companies are dominant in the market mainly due to their well-established presence in the field of contrast injector, presence in over 50 countries, high R&D investments, and strong sales and distribution force. Other players include Medtron AG (Germany), ulrich GmbH & Co. KG (Germany), GE Healthcare (U.S.), AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), VIVID IMAGING (China), and Apollo RT Co., Ltd. (China).

Stakeholders of the Contrast Injector Market

  • Contrast Injector Manufacturers and Distributors
  • Contrast Media/Contrast Agent Manufacturers and Distributors
  • Companies Manufacturing X-ray, CT, MRI, and Cath Lab Equipment
  • Niche Companies Manufacturing Novel Contrast Agents and Contrast Injectors
  • Healthcare Institutions (Hospitals, Academic Medical Centers, and Outpatient Clinics)
  • Radiology Centers
  • Medical Imaging & Nuclear Medicine Consultants
  • Health Insurance Players
  • Research and Consulting Firms

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

This research report categorizes the global contrast injector market into the following segments:

Contrast Injectors Market, by Product

  • Injector Systems
    • CT Injector Systems
    • MRI Injector Systems
    • Angiography Injector Systems
  • Consumables
    • Injector Heads
      • Single Head Injectors
      • Dual Head Injectors
      • Syringeless Injectors
    • Tubing
    • Syringe
    • Other Consumables
  • Accessories

Contrast Injectors Market, by Application

  • Radiology
  • Interventional Cardiology
  • Interventional Radiology

Contrast Injectors Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • EU-3
    • RoE
  • Asia-Pacific
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization option is available for the report:

Portfolio Assessment

Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies in the market.

Interventional cardiology segment to grow at the highest CAGR during the forecast period

On the basis of application, the global contrast media injectors market is segmented into interventional radiology, and interventional cardiology applications. The radiology segment is expected to account for the largest share of the global contrast media injectors market whereas the interventional cardiology segment is expected to grow at the highest CAGR. The growth of the market can be attributed to the high global CVD burden. According to the World Heart Federation (WHF), by 2030, nearly 23.6 million people are predicted to die worldwide from CVD. This is leading to an increase in the demand for cardiac intervention procedures and coronary diagnostic procedures.

The global contrast media injectors market is expected to reach USD 636.1 million by 2021. Factors such as increasing number of approvals for contrast agents, increasing number of public and private diagnostic centers, technological advancements in the contrast media injector arena and the increased focus of market players in the injector technology provide high growth opportunities for players in the global contrast media injectors market.

Development of gamma and neutron solutions, need for highly skilled professionals, and the development of biomarkers, are the major restraints for the market.

A major concern with automated systems is that it is not preferred over manual contrast injectors. Manual contrast injectors account for the largest share of the available contrast media injectors in the market. It is one of the preferred methods to inject contrast media by radiologists in diagnostic labs. In addition, the cost of manual injectors is very low as compared to automatic injectors. Therefore, hospitals avoid the use of automatic injectors for cost saving.

Venous air embolism is a major risk associated with the pressure injector syringes and its tubes. Various effects of air embolism include air hunger, dyspnea, cough, chest pain, pulmonary edema, tachycardia, hypotension, or expiratory wheezing. This may also result in neurologic deficits, for example stroke, due to the decreased cardiac output or paradoxical air embolism (Source: 2016, American College of Radiology U.S. Manual). Other risks associated include sepsis which may be caused by improper handling of contrast agent syringes. Such risks associated with the use of contrast media injectors are restraining their usage and thus, restricting the growth of the market to some extent.

However, the drawbacks of manual devices like wastage of contrast media, and chances of contamination as well as technological advancements like syringeless and dual-head injectors and IT enaenabled contrast media injectors are likely to offer lucrative growth opportunities for players in the contrast media injectors market.

Market Dynamics

Contrast Injector Market

The MRI injector systems segment is the fastest-growing product segment of the global injector systems market

CT Injector Systems

Large number of approvals for contrast agents and technological advancements in the field of injector technologies are some of the factors driving the demand for CT injector systems. Market players such as Guerbet Group (France) and Bracco Imaging S.p.A (Italy) have introduced syringeless injectors for CT scanners.

MRI Injector Systems

Increasing focus of market players to introduce technologically advanced injector systems is driving the demand for MRI injector systems. For instance, in November 2016, ulrich medical (Germany) launched two new syringeless MRI contrast media injectors, Max 3 and Max 2M. Both these products are more efficient in comparison to conventional injectors. Furthermore, market players such as Nemoto Kyorindo Co., Ltd. (Japan), Bracco Imaging S.p.A (Italy), and Guerbet Group (France) provide IT-enabled injector solutions. Hospitals can connect MRI scanners and contrast media injectors to the Hospital Information Systems (HIS) or Electronic Medical Record (EMR), and access patient data from Picture Archiving and Communication Systems (PACS).

Angiography Injector Systems

Angiography injectors are used in procedures to examine the coronary and renal arteries, and vasculature of the heart, abdominal organs, brain, and extremities. Market players operating in the field of angiography injector technology have introduced advanced angiography injector systems. For instance, ulrich GmbH & Co. KG (Germany) developed Adam, an angiography injector that is increasingly utilized in angiography procedures. Similarly, Angiomat Illumena by Guerbet Group (France), Medrad Mark 7 Arterion Injection System by Bayer AG (Germany), and PRESS DUO by Nemoto Kyorindo Co., Ltd. (Japan) are some of the significant angiography injector systems.

The injector heads segment accounted for the largest share of the consumables market. This large share is mainly driven by the growing requirement of consumables to maintain safety and hygienic conditions during diagnostic procedures. Consumables are of single use and easily disposable. They need to be re-purchased for every new procedure as opposed to instruments. The injector heads segment has been further segmented into single head, dual head, and syringeless injectors.

Single head injectors

Single head injectors are widely used in CT scans and cath labs that perform angiography procedures. These procedures prefer the use of single head injectors, as they avoid air embolisms. Single head injectors require constant monitoring; wastage of contrast agent serves to be a major factor adding to its disadvantage. Hospitals and radiologists utilize dual head injectors. These injectors require high-pressure and variable flow rates with one head of saline injection to open the veins and other head to inject contrast. This significantly reduces the wastage of contrast agents, thereby reducing the cost of diagnostic procedures. Due to the advantages offered by dual head injectors, radiologists prefer the usage of dual head injectors in comparison to single head injectors. However, with the increasing number of CVD cases, the market for single head injectors is likely to sustain in the coming years.

Dual head injectors

Dual head injectors are designed to intravenously inject saline and contrast agents in the patient’s body. The process involves injecting saline, before and after the contrast agent is injected. The simultaneous flow of saline and contrast agents avoids wastage of contrast agents, thereby reducing the cost of diagnostic procedures. CT scans in hospitals specifically use dual head injectors; the first injector head injects contrast agents and the second head allows the saline to flush and keep the contrast agent flowing in the patient’s body. Moreover, dual-head injectors are efficient in terms of contrast delivery and avoids air embolism.

Syringeless injectors <

Syringeless injectors or syringeless power injectors have gained popularity, as hospitals are focusing on improving operational efficiency and reducing the cost of diagnostic imaging procedures. According to the U.S. Joint Commission, the reuse of unused doses from single-use syringe injectors is banned. Syringeless injector is composed of a softbag, which consists of contrast agent, connected to a hydraulic pump, and tubes to deliver contrast agents to patient. Syringeless injector facilitates the opportunity to utilize contrast agents as efficiently as possible, thereby decreasing contrast media wastage. Syringeless injectors are widely used in combination with CT and MRI scanners.

Market players have introduced syringeless injector compatible with imaging modalities. For instance, in November 2016, Bracco S.p.A (Italy) received an approval from FDA for its syringeless CT injector, CT Expres 3D. Similarly, in November 2016, ulrich GmbH & Co., KG (Germany) launched two new syringeless MRI contrast media injectors, Max 3 and Max 2M.

Key Questions

  • Which product segment is likely to drive the growth of the global contrast media injectors market?
  • What will be the impact of the rise in the number of patients with chronic diseases?
  • How are syringeless and dual-head injectors likely to drive growth?

The contrast injectors market is projected to reach USD 636.1 Million by 2021 from 445.5 Million in 2016, growing at a CAGR of 7.4% during the forecast period. The contrast injector market growth can primarily be attributed to factors such as the large number of approvals for contrast agents in different geographies and increasing number of public and private diagnostic centers. On the other hand, the side effects and allergic reactions associated with contrast agents are expected to limit the market growth to a certain extent.

The global contrast injector market is segmented on the basis of application, product, and region. Based on application, the contrast injector market is segmented into radiology, interventional cardiology, and interventional radiology. The interventional cardiology segment is projected to grow at the highest CAGR during the forecast period. However, the radiology segment is expected to command the largest share of the contrast injector market in 2016.

Based on product, the market is categorized into injector systems, consumables, and accessories. The injector systems category is further segmented into CT injector systems, MRI injector systems, and angiography injector systems. The CT injector systems segment is expected to command the largest share of the market in 2016. The MRI injector systems segment is projected to grow at the highest CAGR during the forecast period. The consumables segment is expected to account for the largest share of the market in 2016. The growth of the consumables segment can largely be attributed to the recurring use in every procedure conducted. The consumables segment is further segmented into injector heads, syringes, tubing, and other consumables (scan bags, valves, vials, and spikes). The injector heads segment is estimated to account for the largest share of the consumables market in 2016. The injector heads segment is further divided into single head injectors, dual head injectors, and syringeless injectors. The single head injectors segment is expected to command the largest share of the market in 2016. The syringeless injectors segment is projected to grow at the highest CAGR during the forecast period.

Based on region, North America is expected to account for the largest share of the global contrast injector market. North America’s leadership position in the market can be attributed to the increase in the number of diagnostics imaging centers and tests, rising prevalence of chronic diseases, increasing aging population in the U.S., increasing number of cardiac arrests, and rising incidence of diseases. In the coming years, the contrast injector market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in the region can be attributed to the rising approvals for various contrast agents in Asia-Pacific countries, developing markets, and the growing presence of international players in this region. In addition, the availability of government support for research, high healthcare expenditure in APAC countries, increase in aging population, and increasing cancer incidences are expected to support the growth of the Asia-Pacific contrast injector market.

Contrast Injector Market

Key players in the global contrast injectors market include Bracco Imaging S.p.A. (Italy), Bayer HealthCare (Germany), Guerbet Group (France), Medtron AG (Germany), ulrich GmbH & Co. KG (Germany), GE Healthcare (U.S.), AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), VIVID IMAGING (China), and Apollo RT Co., Ltd. (China).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 16)
    2.1 Research Methodology Steps
           2.1.1 Secondary and Primary Research Methodology
                    2.1.1.1 Secondary Research
                               2.1.1.1.1 Key Data From Secondary Sources
                    2.1.1.2 Primary Research
                               2.1.1.2.1 Key Insights From Primary Sources
                    2.1.1.3 Key Industry Insights
           2.1.2 Market Size Estimation Methodology
           2.1.3 Research Design
           2.1.4 Market Data Validation and Triangulation
           2.1.5 Assumptions

3 Executive Summary (Page No. - 26)
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights (Page No. - 29)
    4.1 Contrast Injectors: Market Overview
    4.2 Contrast Injectors Market, By Application and  By Product
    4.3 Contrast Injectors Market, By Application and  By Region
    4.4 Geographic Snapshot: Contrast Injectors Market

5 Market Overview (Page No. - 32)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Large Number of Approvals for Contrast Agents
                    5.2.1.2 Increasing Number of Public and Private Diagnostic Centers
           5.2.2 Restraints
                    5.2.2.1 Risks Associated With Contrast Media Injectors
                    5.2.2.2 High Cost of Contrast Media Injectors and Consumables & Accessories
                    5.2.2.3 Reluctance to Adopt New Technology
           5.2.3 Opportunities
                    5.2.3.1 Technological Advancements in Contrast Media Injectors Arena
                               5.2.3.1.1 It-Enabled Solutions for Contrast Media Injectors
                               5.2.3.1.2 Syringeless and Dual-Head Injectors
                    5.2.3.2 Increasing Focus of Market Players on Contrast Media Injector Arena
           5.2.4 Challenges
                    5.2.4.1 Development of Gamma and Neutron Imaging Solutions
                    5.2.4.2 Shortage of and Need for Highly Skilled Professionals
                    5.2.4.3 Development of Biomarkers

6 Global Contrast Injectors Market, By Product (Page No. - 38)
    6.1 Introduction
    6.2 Injector Systems
           6.2.1 CT Injector Systems
           6.2.2 MRI Injector Systems
           6.2.3 Angiography Injector Systems
    6.3 Consumables
           6.3.1 Injector Heads
                    6.3.1.1 Single Head Injectors
                    6.3.1.2 Dual Head Injectors
                    6.3.1.3 Syringeless Injectors
           6.3.2 Syringes
           6.3.3 Tubing
           6.3.4 Other Consumables
    6.4 Accessories

7 Global Contrast Injectors Market, By Application (Page No. - 51)
    7.1 Introduction
    7.2 Radiology
    7.3 Interventional Cardiology
    7.4 Interventional Radiology

8 Contrast Injectors Market, By Region (Page No. - 57)
    8.1 Introduction
    8.2 North America
           8.2.1 U.S.
                    8.2.1.1 Increasing Number of Diagnostic Imaging Tests and Centers
                    8.2.1.2 Rising Prevalence of Chronic Diseases and Increasing Aging Population
                    8.2.1.3 Prevalence of Alzheimer’s Disease and Other Dementias
           8.2.2 Canada
                    8.2.2.1 Rising Aging Population, High Incidence of Cancer, CVD, and Diabetes
                    8.2.2.2 MRI and CT Examinations Likely to Boost the Market
                    8.2.2.3 Increasing Number of Cardiac Arrest Cases
    8.3 Europe
           8.3.1 Europe 3
                    8.3.1.1 Germany: Increasing Number of Diagnostic Imaging Procedures
                    8.3.1.2 France: Increasing Incidences and Prevalence of Cancer
                    8.3.1.3 U.K.: Lack of Sufficient Instruments
           8.3.2 RoE
                    8.3.2.1 Increased Focus of Market Players on RoE Countries
                    8.3.2.2 Russia: Initiatives By Government to Improve Healthcare
    8.4 Asia-Pacific
           8.4.1 Rise in Aging Population and Cancer Incidence
           8.4.2 Expansion of International Players in China and India
           8.4.3 Favorable Regulatory Changes in New Zealand and Australia
           8.4.4 Healthcare Reforms, Government Initiatives, and Investments in China
    8.5 Rest of the World
           8.5.1 Latin America
           8.5.2 The Middle East
           8.5.3 Africa

9 Competitive Landscape (Page No. - 92)
    9.1 Overview
    9.2 Market Share Analysis
           9.2.1 Bracco Imaging S.P.A
           9.2.2 Bayer Healthcare
           9.2.3 Guerbet Group
    9.3 Competitive Scenario
           9.3.1 Other Strategies
           9.3.2 Product Deployment
           9.3.3 Product Launch
           9.3.4 Market Developments (Product Approvals)

10 Company Profiles (Page No. - 98)
(Overview, Financial*, Products & Services, Strategy, and Developments)
     10.1 Bayer AG (Medrad Inc.)
     10.2 Bracco Imaging S.P.A.
     10.3 Guerbet Group
     10.4 Ulrich GmbH & Co. Kg.
     10.5 Nemoto Kyorindo Co., Ltd
     10.6 Sino Medical-Device Technology Co., Ltd. (SinoMDT)
     10.7 Apollo RT  Co., Ltd.
     10.8 Vivid Imaging
     10.9 Angiodynamics (Navilyst Medical, Inc)
     10.10 GE Healthcare

*Details Might Not Be Captured in Case of Unlisted Companies.

11 Appendix (Page No. - 117)
     11.1 Discussion Guide
     11.2 Knowledge Store: Marketsandmarkets Subscription Portal
     11.3 Introducing RT: Real-Time Market Intelligence
     11.4 Available Customizations
     11.5 Related Reports
     11.6 Author Details


List of Tables (69 Tables)

Table 1 Global Contrast Injectors Market Size, By Product, 2014–2021 (USD Million)
Table 2 Contrast Injector Systems Market Size, By Region, 2014–2021 (USD Million)
Table 3 Contrast Injector Systems Market Size, By Type, 2014–2021 (USD Million)
Table 4 Contrast CT Injector Systems Market Size, By Region, 2014–2021 (USD Million)
Table 5 Contrast MRI Injector Systems Market Size, By Region, 2014–2021 (USD Million)
Table 6 Contrast Angiography Injector Systems Market Size, By Region, 2014–2021 (USD Million)
Table 7 Contrast Injector Consumables Market Size, By Region, 2014–2021 (USD Million)
Table 8 Contrast Injector Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 9 Contrast Injector Heads Market Size, By Region, 2014–2021 (USD Million)
Table 10 Contrast Injector Heads Market Size, By Type, 2014–2021 (USD Million)
Table 11 Single Head Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 12 Dual Head Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 13 Syringeless Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 14 Contrast Injector Syringes Market Size, By Region, 2014–2021 (USD Million)
Table 15 Contrast Injector Tubing Market Size, By Region, 2014–2021 (USD Million)
Table 16 Other Contrast Injector Consumables Market Size, By Region, 2014–2021 (USD Million)
Table 17 Contrast Injector Accessories Market Size, By Region, 2014–2021 (USD Million)
Table 18 Contrast Injectors Market Size, By Application, 2014–2021 (USD Million)
Table 19 Contrast Injectors Market Size for Radiology, By Region, 2014–2021 (USD Million)
Table 20 Contrast Injectors Market Size for Interventional Cardiology, By Region, 2014–2021 (USD Million)
Table 21 Contrast Injectors Market Size for Interventional Radiology, By Region, 2014–2021 (USD Million)
Table 22 Contrast Injector Market Size, By Region, 2014-2021 (USD Million)
Table 23 North America: Contrast Injectors Market Size, By Country, 2014-2021 (USD Million)
Table 24 North America: Contrast Injector Market Size, By Product, 2014-2021 (USD Million)
Table 25 North America: Contrast Injectors Market Size, By Injector System Type, 2014-2021 (USD Million)
Table 26 North America: Contrast Injectors Market Size, By Consumables Type, 2014-2021 (USD Million)
Table 27 North America: Contrast Injectors Market Size, By Injector Head Type, 2014-2021 (USD Million)
Table 28 North America: Contrast Injector Market Size, By Application, 2014-2021 (USD Million)
Table 29 U.S.: Contrast Injectors Market Size, By Product, 2014-2021 (USD Million)
Table 30 U.S.: Contrast Injector Market Size, By Injector System Type, 2014-2021 (USD Million)
Table 31 U.S.: Contrast Injectors Market Size, By Consumables Type, 2014-2021 (USD Million)
Table 32 U.S.: Contrast Injector Market Size, By Injector Head Type, 2014-2021 (USD Million)
Table 33 U.S.:  Contrast Injectors Market Size, By Application, 2014-2021 (USD Million)
Table 34 Canada: Contrast Injectors Market Size, By Product, 2014-2021 (USD Million)
Table 35 Canada: Contrast Injectors Market Size, By Injector System Type, 2014-2021 (USD Million)
Table 36 Canada: Contrast Injectors Market Size, By Consumables Type, 2014-2021 (USD Million)
Table 37 Canada: Contrast Injectors Market Size, By Injector Head Type, 2014-2021 (USD Million)
Table 38 Canada: Contrast Injectors Market Size, By Application, 2014-2021 (USD Million)
Table 39 Europe: Contrast Injectors Contrast Injector Market Size, By Country, 2014-2021 (USD Million)
Table 40 Europe: Contrast Injectors Market Size, By Product, 2014-2021 (USD Million)
Table 41 Europe: Contrast Injectors Market Size, By Injector System Type, 2014-2021 (USD Million)
Table 42 Europe: Contrast Injectors Market Size, By Consumables Type, 2014-2021 (USD Million)
Table 43 Europe: Contrast Injector Market Size, By Injector Head Type, 2014-2021 (USD Million)
Table 44 Europe: Contrast Injectors Market Size, By Application, 2014-2021 (USD Million)
Table 45 Europe 3: Contrast Injector Market Size, By Product, 2014-2021 (USD Million)
Table 46 Europe 3: Contrast Injector Market Size, By Injector System Type, 2014-2021 (USD Million)
Table 47 Europe 3: Market Size, By Consumables Type, 2014-2021 (USD Million)
Table 48 Europe 3: Contrast Injector Market Size, By Injector Head Type, 2014-2021 (USD Million)
Table 49 Europe 3: Market Size, By Application, 2014-2021 (USD Million)
Table 50 RoE: Contrast Injector Market Size, By Product, 2014-2021 (USD Million)
Table 51 RoE: Market Size, By Injector System Type, 2014-2021 (USD Million)
Table 52 RoE: Contrast Injector Market Size, By Consumables Type, 2014-2021 (USD Million)
Table 53 RoE: Contrast Injector Market Size, By Injector Head Type, 2014-2021 (USD Million)
Table 54 RoE: Market Size, By Application, 2014-2021 (USD Million)
Table 55 Asia-Pacific: Market Size, By Product, 2014-2021 (USD Million)
Table 56 Asia-Pacific: Contrast Injector Market Size, By Injector System Type, 2014-2021 (USD Million)
Table 57 Asia-Pacific: Market Size, By Consumables Type, 2014-2021 (USD Million)
Table 58 Asia-Pacific: Contrast Injector Market Size, By Injector Head Type, 2014-2021 (USD Million)
Table 59 Asia-Pacific: Contrast Injector Market Size, By Application, 2014-2021 (USD Million)
Table 60 RoW: Contrast Injectors Market Size, By Product, 2014-2021 (USD Million)
Table 61 RoW: Contrast Injectors Market Size, By Injector System Type, 2014-2021 (USD Million)
Table 62 RoW: Contrast Injectors Market Size, By Consumables Type, 2014-2021 (USD Million)
Table 63 RoW: Contrast Injectors Market Size, By Injector Head Type, 2014-2021 (USD Million)
Table 64 RoW: Contrast Injectors Market Size, By Application, 2014-2021 (USD Million)
Table 65 Key Player’s Ranking in the Contrast Injector Market (2016)
Table 66 Other Strategies, 2014–2016
Table 67 Product Deployment, 2014–2016
Table 68 Product Launch, 2013–2016
Table 69 Market Developments (Product Approvals), 2013–2016
 
 
List of Figures (32 Figures)
 
Figure 1 Research Methodology: Global Contrast Injectors Market
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Sampling Frame: Primary Research
Figure 4 Key Data From Primary Sources
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Research Design: Global Contrast Injectors Market
Figure 8 Data Triangulation Methodology
Figure 9 Contrast Injectors Market, By Product
Figure 10 Contrast Injectors Market Analysis, By Application, 2016 vs 2021
Figure 11 Asia-Pacific is Expected to Witness the Highest Growth in the Contrast Injectors Market During the Forecast Period
Figure 12 North America Estimated to Account for the Largest Market Share in 2016
Figure 13 Consumables Segment Estimated to Lead the Market in 2016
Figure 14 Radiology is Estimated to Be the Largest Application, 2016
Figure 15 Asia-Pacific to Witness Highest Growth During the Forecast Period
Figure 16 Drivers, Restraints, Opportunities & Challenges
Figure 17 The Consumables Segment is the Fastest-Growing Product Segment of the Global Contrast Injectors Market
Figure 18 Radiology to Account for the Largest Share of the Contrast Injectors Market, By Application (2016)
Figure 19 North America to Command the Largest Share of the Contrast Injector Market
Figure 20 North America: Contrast Injector Market Snapshot
Figure 21 Prevalence of Alzheimer's Disease in the U.S., By Age Group, 2015
Figure 22 Europe: Contrast Market Snapshot
Figure 23 Asia-Pacific: Contrast Injector Market Snapshot
Figure 24 RoW: Contrast Market Snapshot
Figure 25 Key Developments of the Prominent Players in the Contrast Injector Market (2013-2016)
Figure 26 Other Strategies Key Growth Strategy Adopted By Market Players From 2013 to 2016
Figure 27 Product Mix of the Prominent Players in the Contrast Injector Market
Figure 28 Bayer Healthcare: Company Snapshot
Figure 29 Bracco Imaging S.P.A: Company Snapshot (2015)
Figure 30 Guerbet Group: Company Snapshot (2015)
Figure 31 Angiodynamics: Company Snapshot (2015)
Figure 32 GE Healthcare: Company Snapshot 


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 5244
Published ON
May, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Contrast Injectors Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved